2024 / 02

Next Paper
DOI: 10.47183/mes.2024.026
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Method to assess the effects of bioactive compounds solutions on blood clotting

Manuvera VA1,2, Brovina KA1,2, Bobrovsky PA1,2, Grafskaia EN1, Kharlampieva DD1, Lazarev VN1,2
About authors

1 Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of the Federal Medical Biological Agency, Moscow, Russia

2 Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, Moscow Region, Russia

Correspondence should be addressed: Valentin A. Manuvera
Malaya Pirogovskaya, 1A, Moscow, 119435, Russia; ur.xednay@arevunamv

About paper

Funding: the study was supported by the Russian Science Foundation grant No. 23-25-00006, https://rscf.ru/project/23-25-00006/.

Author contribution: Manuvera VA — concept, experiments, manuscript writing; Brovina KA — experiments, manuscript editing; Bobrovsky PA — data analysis, visualization, manuscript editing; Grafskaia EN — experiments, manuscript editing; Kharlampieva DD — experiments, manuscript editing; Lazarev VN — research team management, manuscript editing.

Received: 2024-03-27 Accepted: 2024-06-15 Published online: 2024-06-28
|
  1. Barkagan ZS. Diagnostika i kontroliruemaja terapija narushenij gemostaza. Moskva: OOO "Mediko-tehnologicheskoe predprijatie «N'judiamed», 2008; 292 s. Russian.
  2. Winter W, Flax S, Harris N. Coagulation testing in the core laboratory. Laboratory Medicine. 2017; 48 (4): 295–313. Available from: https://doi.org/10.1093/labmed/.
  3. Makarov VA, Spasov AA, Plotnikov MB, Belozerskaja GG, Vasileva TM, Drozd NN, i dr. Metodicheskie rekomendacii po izucheniju lekarstvennyh sredstv, vlijajushhih na gemostaz. V knige: Mironov AN, Bunjatjan ND, Vasil'ev AN, Verstakova OL, Zhuravleva MV, Lepahin VK, i dr, redaktory. Rukovodstvo po provedeniju doklinicheskih issledovanij lekarstvennyh sredstv. Chast' pervaja. M.: Grif i K, 2012; s. 453–479. Russian.
  4. Manuvera VA, Kharlampieva DD, Bobrovsky PA, Grafskaia EN, Brovina KA, Lazarev VN. New anticoagulant protein from medicinal leech. Biochemical and Biophysical Research Communications. 2024; 696: 149473. Available from: https://doi.org/10.1016/j.bbrc.2024.149473
  5. Nutt EM, Jain D, Lenny AB, Schaffer L, Siegl PK, Dunwiddie CT, Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa, Arch Biochem Biophys. 1991; 285: 37–44. Available from: https://doi.org/10.1016/0003-9861(91)90325-D.
  6. Müller C, Mescke K, Liebig S, et al. More than just one: multiplicity of Hirudins and Hirudin-like Factors in the Medicinal Leech, Hirudo medicinalis. Mol Genet Genomics. 2016; 291: 227–240. Available from: https://doi.org/10.1007/s00438-015-1100-0.
  7. Onishi A, St Ange K, Dordick JS, Linhardt RJ. Heparin and anticoagulation. Front Biosci Landmark Ed. 2016; 21 (7): 1372– 92. Available from: https://doi.org/10.2741/4462.